Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Aerts

Showing results (91-100 of 360) with videos related to

Pageof 36
Sort By:
Chemistry & Biology|August 16, 2014
ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's diseaseYun Lei Tan, Joseph C Genereux, Sandra Pankow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 29, 2019
Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancerMark de Mol, Sabine Visser, Brenda L den Oudsten, et al.
Clinical Immunology (Orlando, Fla.)|March 25, 2009
Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosyAnand Iyer, Marco van Eijk, Eliane Silva, et al.
FEBS Letters|June 15, 2010
Curdlan-mediated regulation of human phagocyte-specific chitotriosidaseMarco van Eijk, Tineke Voorn-Brouwer, Saskia S Scheij, et al.
Current Medical Research and Opinion|May 31, 2012
Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE studyJ G Aerts, A Swieboda-Sadlej, C Karanikiotis, et al.
AJR. American Journal of Roentgenology|September 20, 2002
Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameterMario Maas, Carla E M Hollak, Erik M Akkerman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 6, 2007
Monitoring of Gaucher patients with a novel chitotriosidase assayAricha Schoonhoven, Bernard Rudensky, Debbie Elstein, et al.
Metabolism: Clinical and Experimental|February 13, 2007
Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemiaMirjam Langeveld, Saskia Scheij, Peter Dubbelhuis, et al.
Analytical Biochemistry|October 18, 2008
Detection of chitinase activity by 2-aminobenzoic acid labeling of chito-oligosaccharidesKaren Ghauharali-van der Vlugt, Anton P Bussink, Johanna E M Groener, et al.
Biochimica Et Biophysica Acta|December 25, 2007
Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic interventionJ E M Groener, B J H M Poorthuis, S Kuiper, et al.
Pageof 36

Showing results (91-100 of 360) with videos related to

Sort By:
Pageof 36
Chemistry & Biology|August 16, 2014
ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's diseaseYun Lei Tan, Joseph C Genereux, Sandra Pankow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 29, 2019
Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancerMark de Mol, Sabine Visser, Brenda L den Oudsten, et al.
Clinical Immunology (Orlando, Fla.)|March 25, 2009
Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosyAnand Iyer, Marco van Eijk, Eliane Silva, et al.
FEBS Letters|June 15, 2010
Curdlan-mediated regulation of human phagocyte-specific chitotriosidaseMarco van Eijk, Tineke Voorn-Brouwer, Saskia S Scheij, et al.
Current Medical Research and Opinion|May 31, 2012
Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE studyJ G Aerts, A Swieboda-Sadlej, C Karanikiotis, et al.
AJR. American Journal of Roentgenology|September 20, 2002
Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameterMario Maas, Carla E M Hollak, Erik M Akkerman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 6, 2007
Monitoring of Gaucher patients with a novel chitotriosidase assayAricha Schoonhoven, Bernard Rudensky, Debbie Elstein, et al.
Metabolism: Clinical and Experimental|February 13, 2007
Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemiaMirjam Langeveld, Saskia Scheij, Peter Dubbelhuis, et al.
Analytical Biochemistry|October 18, 2008
Detection of chitinase activity by 2-aminobenzoic acid labeling of chito-oligosaccharidesKaren Ghauharali-van der Vlugt, Anton P Bussink, Johanna E M Groener, et al.
Biochimica Et Biophysica Acta|December 25, 2007
Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic interventionJ E M Groener, B J H M Poorthuis, S Kuiper, et al.
Pageof 36